Crystal Mackall

29PUBLICATIONS
176CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsGene and molecular therapySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Nov 02, 2026
Clonal hematopoiesis and cytopenias following CAR19 therapy.

|Mar 10, 2026
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer.

Gregory M Chen, Ankita Jain, David T Gering

|Nov 24, 2025
CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopenias.

Mark P Hamilton, Nick Phillips, Troy Noordenbos

|Apr 23, 2025
IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignancies.

Pablo Domizi, Jolanda Sarno, Astraea Jager

|Nov 13, 2024
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas.

Michelle Monje, Jasia Mahdi, Robbie Majzner

|Oct 06, 2024
GLUT1 overexpression in CAR-T cells induces metabolic reprogramming and enhances potency.

Justin A Guerrero, Dorota D Klysz, Yiyun Chen

Pageof 5

Frequent Collaborators

10 joint publications

Robbie Majzner

8 joint publications

Michelle Monje

8 joint publications

Elena Sotillo

7 joint publications

Kara L Davis